Press Releases
AstraZeneca enters commercialisation agreement with Aspen for anaesthetic medicines...
Agreement expands commercial reach for anaesthetics and supports the Company’s sharp focus on innovative new medicines in its three main therapy areas. ...
Press Releases
PCI Pharma Services’ Hay-on-Wye Site Launches New 3D Camera...
PCI Pharma Services is installing specialist, innovative three-dimensional (3D) and high resolution color camera technology for product inspection and fill control on three of its...
Press Releases
Janssen Phase 3 Data Severely Active Rheumatoid Arthritis ...
Janssen Research & Development, LLC announced results from a pivotal Phase 3 study evaluating subcutaneous sirukumab (CNTO 136), a human anti-interleukin (IL)-6 monoclonal antibody in...
Press Releases
Pfizer Announces FDA Advisory Committees Recommend ALO-02 Extended-Release Capsules...
Pfizer Inc. announced that the U.S. FDA Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee voted (9 to...
Press Releases
ALF 5000: New Filling and Closing Machine for Ampoules...
Increased performance and higher safety Output of up to 600 containers per minute Flexible use: compatible with all commonfilling systems ...
Press Releases
AstraZeneca,Ironwood enter U.S. licensing agreement for lesinurad
AstraZeneca announced that it has completed the licensing agreement with Ironwood Pharmaceuticals for the exclusive US rights to Zurampic (lesinurad) and the fixed-dose combination of...
Press Releases
Shire Plc completes combination with Baxalta Inc creating global...
Shire plc completed its previously announced combination with Baxalta Incorporated ,creating the leading global biotechnology company focused on serving patients with rare diseases and other...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.